|
|
copper ion homeostasis
|
GO:0055070 |
9 |
1.000
|
|
|
|
cellular copper ion homeostasis
|
GO:0006878 |
8 |
1.000
|
|
|
|
rna polyadenylation
|
GO:0043631 |
6 |
1.000
|
|
|
|
regulation of epidermal growth factor activated receptor activity
|
GO:0007176 |
7 |
1.000
|
|
|
|
mrna polyadenylation
|
GO:0006378 |
5 |
1.000
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.999
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.998
|
|
|
|
axon cargo transport
|
GO:0008088 |
33 |
0.996
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.996
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.995
|
|
|
|
ionotropic glutamate receptor signaling pathway
|
GO:0035235 |
29 |
0.991
|
|
|
|
endoplasmic reticulum calcium ion homeostasis
|
GO:0032469 |
11 |
0.991
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
32 |
0.990
|
|
|
|
visual learning
|
GO:0008542 |
44 |
0.983
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.981
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.980
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.969
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.961
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.953
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.948
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.935
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.929
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.920
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.918
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.916
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.901
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.890
|
|
|
|
positive regulation of g2 m transition of mitotic cell cycle
|
GO:0010971 |
5 |
0.888
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.887
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.879
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.870
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.867
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.853
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.850
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.849
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.848
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.843
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.839
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.838
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.807
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.799
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.792
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.790
|
|
|
|
regulation of epidermal growth factor receptor signaling pathway
|
GO:0042058 |
13 |
0.789
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.780
|
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
35 |
0.779
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.773
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.773
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.772
|
|
|
|
learning
|
GO:0007612 |
98 |
0.772
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.763
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.756
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.751
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.750
|
|
|
|
regulation of erbb signaling pathway
|
GO:1901184 |
16 |
0.746
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.739
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.736
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.726
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.723
|
|
|
|
regulation of membrane protein ectodomain proteolysis
|
GO:0051043 |
3 |
0.700
|
|
|
|
positive regulation of membrane protein ectodomain proteolysis
|
GO:0051044 |
3 |
0.688
|
|
|
|
peptidyl proline hydroxylation
|
GO:0019511 |
3 |
0.671
|
|
|
|
inclusion body assembly
|
GO:0070841 |
3 |
0.650
|
|
|
|
regulation of beta amyloid clearance
|
GO:1900221 |
1 |
0.645
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.642
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.638
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.625
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.624
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.613
|
|
|
|
positive regulation of beta amyloid formation
|
GO:1902004 |
4 |
0.613
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.610
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.607
|
|
|
|
smooth endoplasmic reticulum calcium ion homeostasis
|
GO:0051563 |
2 |
0.591
|
|
|
|
negative regulation of cellular amide metabolic process
|
GO:0034249 |
4 |
0.587
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.580
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.578
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.573
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.572
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.572
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.568
|
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.565
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.557
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.551
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.551
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.549
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.548
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.544
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.536
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.532
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.525
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.524
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.522
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.521
|
|
|
|
regulation of inclusion body assembly
|
GO:0090083 |
1 |
0.514
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.511
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.494
|
|
|
|
neuron recognition
|
GO:0008038 |
25 |
0.488
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.484
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.477
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.476
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.473
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.451
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.439
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.439
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.437
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.435
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.430
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.427
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.413
|
|
|
|
vesicle docking involved in exocytosis
|
GO:0006904 |
7 |
0.412
|
|
|
|
positive regulation of fibronectin dependent thymocyte migration
|
GO:2000415 |
1 |
0.410
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.408
|
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
6 |
0.405
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.404
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.400
|
|
|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.398
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.397
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.396
|
|
|
|
terminal button organization
|
GO:0072553 |
3 |
0.394
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.380
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.376
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.376
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.376
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.372
|
|
|
|
regulation of g2 m transition of mitotic cell cycle
|
GO:0010389 |
10 |
0.371
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.357
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.356
|
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.355
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.352
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.350
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.345
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.343
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.338
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.335
|
|
|
|
cholesterol catabolic process
|
GO:0006707 |
5 |
0.331
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.329
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.320
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.316
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.316
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.315
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.312
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.307
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.305
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.302
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.300
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.299
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.298
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.295
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.287
|
|
|
|
sodium ion export
|
GO:0071436 |
2 |
0.286
|
|
|
|
locomotory exploration behavior
|
GO:0035641 |
10 |
0.286
|
|
|
|
regulation of neurofibrillary tangle assembly
|
GO:1902996 |
1 |
0.285
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.284
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.283
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.276
|
|
|
|
translation
|
GO:0006412 |
93 |
0.276
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.274
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.273
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.265
|
|
|
|
long term memory
|
GO:0007616 |
15 |
0.263
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.262
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.261
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
31 |
0.258
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.255
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.252
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.246
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.244
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.244
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.239
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.239
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.239
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.236
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.236
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.232
|
|
|
|
beta amyloid metabolic process
|
GO:0050435 |
14 |
0.232
|
|
|
|
negative regulation of beta amyloid formation
|
GO:1902430 |
4 |
0.231
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.227
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.226
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.223
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.222
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.222
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.220
|
|
|
|
mating behavior
|
GO:0007617 |
20 |
0.219
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.218
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.217
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.216
|
|
|
|
homophilic cell adhesion via plasma membrane adhesion molecules
|
GO:0007156 |
18 |
0.216
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.215
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.214
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.213
|
|
|
|
positive regulation of amyloid precursor protein catabolic process
|
GO:1902993 |
4 |
0.210
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.209
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.206
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.205
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.204
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.204
|
|
|
|
response to misfolded protein
|
GO:0051788 |
5 |
0.203
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.200
|
|
|
|
adherens junction maintenance
|
GO:0034334 |
1 |
0.198
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.198
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.197
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.196
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.195
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.194
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.193
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.192
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.190
|
|
|
|
positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000060 |
8 |
0.189
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.189
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.188
|
|
|
|
protein folding
|
GO:0006457 |
28 |
0.185
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.185
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.184
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.183
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.183
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.182
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.182
|
|
|
|
clathrin mediated endocytosis
|
GO:0072583 |
7 |
0.179
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.177
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.175
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.174
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.172
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.170
|
|
|
|
membrane protein proteolysis
|
GO:0033619 |
10 |
0.170
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.169
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.169
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.168
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.168
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.166
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.166
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.166
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.166
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.165
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.165
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.165
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.164
|
|
|
|
memory
|
GO:0007613 |
58 |
0.164
|
|
|
|
sterol catabolic process
|
GO:0016127 |
5 |
0.161
|
|
|
|
negative regulation of amyloid precursor protein catabolic process
|
GO:1902992 |
5 |
0.160
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.158
|
|
|
|
response to topologically incorrect protein
|
GO:0035966 |
25 |
0.158
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.157
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.155
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.152
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.150
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.149
|
|
|
|
exploration behavior
|
GO:0035640 |
21 |
0.149
|
|
|
|
peptidyl proline hydroxylation to 4 hydroxy l proline
|
GO:0018401 |
2 |
0.148
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.147
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.146
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.145
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.142
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.142
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.139
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.138
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.138
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.137
|
|
|
|
regulation of response to reactive oxygen species
|
GO:1901031 |
9 |
0.136
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.135
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.134
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.134
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.134
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.133
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.132
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.131
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.131
|
|
|
|
vesicle docking
|
GO:0048278 |
7 |
0.130
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.130
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.130
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.128
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.126
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.126
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.126
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.125
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.125
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.125
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.125
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.123
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.122
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.122
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.121
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.121
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.120
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.120
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.119
|
|
|
|
response to ammonium ion
|
GO:0060359 |
21 |
0.119
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.117
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.117
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.116
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.116
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.116
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.115
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.115
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.115
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.114
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.114
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.114
|
|
|
|
extracellular matrix dependent thymocyte migration
|
GO:0072680 |
1 |
0.114
|
|
|
|
positive regulation of cell cycle g2 m phase transition
|
GO:1902751 |
5 |
0.114
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.113
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.113
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
25 |
0.112
|
|
|
|
fibronectin dependent thymocyte migration
|
GO:0072681 |
1 |
0.110
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.108
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.108
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.107
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.105
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.105
|
|
|
|
leukocyte migration involved in inflammatory response
|
GO:0002523 |
7 |
0.105
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.105
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.102
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.102
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.102
|
|
|
|
protein stabilization
|
GO:0050821 |
25 |
0.100
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.100
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.100
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.100
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.100
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.099
|
|
|
|
positive regulation of potassium ion transmembrane transport
|
GO:1901381 |
3 |
0.099
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.099
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.098
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.098
|
|
|
|
regulation of amyloid precursor protein catabolic process
|
GO:1902991 |
8 |
0.097
|
|
|
|
alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor clustering
|
GO:0097113 |
3 |
0.097
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.097
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.097
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.096
|
|
|
|
sperm individualization
|
GO:0007291 |
1 |
0.095
|
|
|
|
phagosome maturation
|
GO:0090382 |
4 |
0.095
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.094
|
|
|
|
protein hydroxylation
|
GO:0018126 |
4 |
0.094
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.094
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.092
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.092
|
|
|
|
regulation of tau protein kinase activity
|
GO:1902947 |
1 |
0.091
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.091
|
|
|
|
response to glycoside
|
GO:1903416 |
2 |
0.091
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.091
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.090
|
|
|
|
positive regulation of sodium ion transport
|
GO:0010765 |
13 |
0.089
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.089
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.088
|
|
|
|
positive regulation of cardiac muscle tissue development
|
GO:0055025 |
19 |
0.088
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.087
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.087
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.086
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.086
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.085
|
|
|
|
regulation of amyloid precursor protein biosynthetic process
|
GO:0042984 |
3 |
0.085
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.085
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.084
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.084
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.084
|
|
|
|
neurofibrillary tangle assembly
|
GO:1902988 |
1 |
0.084
|
|
|
|
protein localization to juxtaparanode region of axon
|
GO:0071205 |
4 |
0.083
|
|
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.083
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.082
|
|
|
|
receptor internalization
|
GO:0031623 |
16 |
0.080
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.080
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.080
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.080
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.079
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.079
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.079
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.078
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.078
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.077
|
|
|
|
potassium ion import
|
GO:0010107 |
1 |
0.076
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
20 |
0.075
|
|
|
|
negative regulation of erbb signaling pathway
|
GO:1901185 |
7 |
0.075
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.074
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.074
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.074
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.073
|
|
|
|
mating
|
GO:0007618 |
27 |
0.073
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.071
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.071
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.071
|
|
|
|
copper ion transport
|
GO:0006825 |
10 |
0.071
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.069
|
|
|
|
cellular response to ethanol
|
GO:0071361 |
3 |
0.068
|
|
|
|
neuron remodeling
|
GO:0016322 |
7 |
0.068
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.068
|
|
|
|
phagocytosis engulfment
|
GO:0006911 |
16 |
0.068
|
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
25 |
0.068
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.066
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.065
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.065
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.065
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.064
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.064
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.063
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.063
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.063
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.063
|
|
|
|
protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:0042787 |
25 |
0.063
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.062
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.062
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.061
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
30 |
0.061
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.061
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.061
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.061
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.061
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.060
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.060
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.060
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.060
|
|
|
|
macrophage activation
|
GO:0042116 |
27 |
0.059
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.059
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.059
|
|
|
|
membrane invagination
|
GO:0010324 |
17 |
0.058
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.058
|
|
|
|
regulation of tumor necrosis factor ligand superfamily member 11 production
|
GO:2000307 |
1 |
0.058
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.058
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.058
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.058
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.057
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.057
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.057
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.056
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.056
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.056
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.055
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.055
|
|
|
|
synaptic vesicle membrane organization
|
GO:0048499 |
1 |
0.055
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.054
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.054
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.053
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.053
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.053
|
|
|
|
response to superoxide
|
GO:0000303 |
16 |
0.052
|
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.051
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.051
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.051
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.050
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.050
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.050
|
|
|
|
substantia nigra development
|
GO:0021762 |
2 |
0.050
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.050
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.050
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.049
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.049
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.049
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.049
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.049
|
|
|
|
cellular sodium ion homeostasis
|
GO:0006883 |
1 |
0.049
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.048
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.048
|
|
|
|
tumor necrosis factor ligand superfamily member 11 production
|
GO:0072535 |
1 |
0.048
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.046
|
|
|
|
regulation of fibronectin dependent thymocyte migration
|
GO:2000413 |
1 |
0.046
|
|
|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
0.046
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.046
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.046
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.046
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.045
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.045
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.045
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.045
|
|
|
|
copper ion transmembrane transport
|
GO:0035434 |
5 |
0.045
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
10 |
0.044
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.044
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.044
|
|
|
|
positive regulation of protein modification by small protein conjugation or removal
|
GO:1903322 |
30 |
0.043
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.043
|
|
|
|
peptidyl proline modification
|
GO:0018208 |
6 |
0.042
|
|